drugset / Trial / NCT00145249
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will examine the effectiveness and safety of a combination treatment for cryptococcal meningitis, a fungal infection common in persons with acquired immune deficiency syndrome (AIDS) in the developing world. The standard initial treatment includes two medications: amphotericin B for 2 weeks followed by 8 weeks of fluconazole. This study will look at whether study participants recover more quickly and have fewer side effects if they are given both drugs at the same time for 2 weeks followed by 8 weeks of fluconazole as compared to the standard treatment. Participants will be followed for approximately 6 months from the time they are enrolled into the study.
Timeline
- Start
- 2005-05
- Primary completion
- 2008-04
- Completion
- 2008-04
Publications
- Results Pappas PG, Chetchotisakd P, Larsen RA, Manosuthi W, Morris MI, Anekthananon T, Sungkanuparph S, Supparatpinyo K, Nolen TL, Zimmer LO, Kendrick AS, Johnson P, Sobel JD, Filler SG. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2009 Jun 15;48(12):1775-83. doi: 10.1086/599112.
- Results Zimmer LO, Nolen TL, Pramanpol S, Wallace D, Walker ME, Pappas P, Chetchotisakd P. International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis. Contemp Clin Trials. 2010 Jan;31(1):34-43. doi: 10.1016/j.cct.2009.11.002. Epub 2009 Nov 6.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amphotericin B | Unknown | 0.7 mg/kg | Intravenous |
| Subject | Fluconazole | Small molecule | 200 mg/kg | Oral |
| Subject | Fluconazole | Small molecule | 400 mg | Oral |
| Subject | Fluconazole | Small molecule | 400 mg/kg | Oral |
| Subject | Fluconazole | Small molecule | 800 mg | Oral |